Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P8ED
|
|||
| Former ID |
DIB013231
|
|||
| Drug Name |
Oncoquest-CLL
|
|||
| Indication | Chronic lymphocytic leukaemia [ICD-11: 2A82.0; ICD-10: C83.0, C91.1] | Phase 2 | [1], [2] | |
| leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Phase 1 | [3] | ||
| Company |
Xeme biopharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | ClinicalTrials.gov (NCT01976520) Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.